Summary
This presolicitation (NIH) requests support for research using radiographic imaging and artificial intelligence/radiomics to predict hepatocellular carcinoma (HCC) risk and recurrence in patients with advanced liver disease or cirrhosis. A portion of funding awarded through the Bench‑to‑Bedside and Back Award Program (Award No. 1517448) will be used to acquire a clinical cohort, imaging datasets, and de‑identified radiology reports from the University of Pennsylvania to support model development. The opportunity is managed by the NIH contracting office in Bethesda, MD and lists a response date of July 23, 2026.